Sosan Mohammadi Kebar, Afshan Shargi, Bahman Bashardoust, Manouchehr Iranparvar, Hossein Fekri, & Afshin Habibzadeh. (2018). The Therapeutic Effects of Sevelamer on Blood Sugar, HbA1c, Lipid Profile, and hs-CRP in Patients with Diabetic Nephropathy. Society of Diabetic Nephropathy Prevention.
Chicago Style (17th ed.) CitationSosan Mohammadi Kebar, Afshan Shargi, Bahman Bashardoust, Manouchehr Iranparvar, Hossein Fekri, and Afshin Habibzadeh. The Therapeutic Effects of Sevelamer on Blood Sugar, HbA1c, Lipid Profile, and Hs-CRP in Patients with Diabetic Nephropathy. Society of Diabetic Nephropathy Prevention, 2018.
MLA (9th ed.) CitationSosan Mohammadi Kebar, et al. The Therapeutic Effects of Sevelamer on Blood Sugar, HbA1c, Lipid Profile, and Hs-CRP in Patients with Diabetic Nephropathy. Society of Diabetic Nephropathy Prevention, 2018.